Abstract
Zusammenfassung. In den vergangenen Jahrzehnten hat sich die Zahl der Ultraläufer vervielfacht, und viele Studien haben den Einfluss auf den Bewegungsapparat untersucht. Wir stellen die Erkenntnisse zu Schäden zusammen, die ein Ultramarathon an Gelenken und Muskeln verursachen kann. Die häufigsten Verletzungen bzw. Überlastungsschäden betreffen die untere Extremität, wobei Sprunggelenk und Knie am häufigsten betroffen sind. Bei sehr langen Läufen kommt es zu einer Anpassung mit Verdickung von Sehnen und Knorpel. Ein Ultramarathon kann zu einem ausgeprägten Muskelschaden führen, mit einem Anstieg von myozellulären Metaboliten wie Myoglobin, Laktat-Dehydrogenase und Creatinkinase.
Abstract. In recent decades, the number of ultra-runners has multiplied. We analyze the findings of previous studies on body damage that can be induced by an ultramarathon. Overuse injuries concern the lower extremity, with ankle and knee being the most commonly affected parts. Very long runs may lead to thickening of tendons and cartilage. An ultramarathon can also lead to pronounced muscle damage with an increase in myocellular metabolites such as myoglobin, lactate dehydrogenase, and creatine kinase.
Résumé. Au cours des dernières décennies, le nombre de coureurs d’ultra-marathon s’est multiplié. Nous avons rassemblé les résultats sur les dégâts que peut provoquer un ultra marathon. Les blessures de surentraînement affectent le membre inférieur, la cheville et le genou le plus souvent. Les très longues courses entraînent une adaptation chronique signalée par l’épaississement des tendons et du cartilage. L’ultramarathon peut provoquer des dommages musculaires prononcés avec une augmentation des métabolites myocellulaires tels que la myoglobine, la lactate déshydrogénase et la créatine kinase.
Bibliografie
Effects of running an ultramarathon on cardiac, hematologic, and metabolic biomarkers. Int J Sports Med 2015; 36: 867–871.
, :Ultramarathon running injuries. In: Doral, MKarlsson,, J (eds.). Sports Injuries: Prevention, Diagnosis, Treatment and Rehabilitation. 2nd ed.Berlin; Springer: 2015. 2889–2898.
:Changes in serum cartilage oligomeric matrix protein (COMP), plasma CPK and plasma hs-CRP in relation to running distance in a marathon (42.195 km) and an ultra-marathon (200 km) race. Eur J Appl Physiol 2009; 105: 765–770.
:Injury and illness rates during ultratrail running. Int J Sports Med 2016; 37: 565–569.
, :Incidence of running-related injuries per 1000 h of running in different types of runners: A systematic review and meta-analysis. Sports Med 2015; 45: 1017–1026.
, :Musculoskeletal injuries in the ultramarathon: The 1990 Westfield Sydney to Melbourne run. Br J Sports Med 1996; 30: 319–323.
:The foot in multistage ultra-marathon runners: Experience in a cohort study of 22 participants of the Trans Europe Footrace Project with mobile MRI. BMJ Open 2012; 2: pii e001118.
:What are the main running-related musculoskeletal injuries? A systematic review. Sports Med 2012; 42: 891–905.
, :Medical implications of ultra marathon running: observations on a six day track race. Br J Sports Med 1984; 18: 44–45.
:A Run for the record: Studies on a trans-American ultramarathoner. JAMA 1981; 245: 367–368.
:MRI of the ankle joint in healthy non-athletes and in marathon runners: image quality issues at 7.0 T compared to 1.5 T. Skeletal Radiol 2013; 42: 261–267.
, :Exercise behavior of ultramarathon runners: Baseline findings from the ultra study. J Strength Cond Res 2013; 27: 2939–2945.
:Ultra-marathon lower limb injuries. In: DoralMNTandoğanRNMannGVerdonk, R (eds.). Sports Injuries: Prevention, Diagnosis, Treatment, and Rehabilitation. Berlin, Springer; 2012. 1109–1111.
:Al andalus ultra trail: An observation of medical interventions during a 219-km, 5-day ultramarathon stage race. Clin J Sport Med 2011; 21: 444–446.
:Do knees survive the Comrades Marathon?S Afr Med J 2008; 98: 873–876.
:Musculoskeletal injuries in a six-day track race: Ultramarathoner’s ankle. Clin J Sport Med 1999; 9: 216–220.
:Study of injury and illness rates in multiday ultramarathon runners. Med Sci Sports Exerc 2011; 43: 2314–2320.
:Injury occurrence and mood states during a desert ultramarathon. Clin J Sport Med 2012; 22: 462–466.
, :The enemy of the feet blisters in ultraendurance runners. J Am Podiatr Med Assoc 2014; 104: 473–478.
:Biochemical cartilage alteration and unexpected signal recovery in T2* mapping observed in ankle joints with mobile MRI during a transcontinental multistage footrace over 4486 km. Osteoarthritis Cartilage 2014; 22: 1840–1850.
:Biomarkers of muscle and cartilage damage and inflammation during a 200 km run. Eur J Appl Physiol 2007; 99: 443–447.
:Effects of prolonged strenuous endurance exercise on plasma myosin heavy chain fragments and other muscular proteins. Cycling vs running. J Sports Med Phys Fitness 1998; 38: 10–17.
, :Shear-wave elastography assessments of quadriceps stiffness changes prior to, during and after prolonged exercise: A longitudinal study during an extreme mountain ultra-marathon. PLoS ONE 2016; 11: e0167668.
, :Acute changes to biomarkers as a consequence of prolonged strenuous running. Ann Clin Biochem 2014; 51: 137–150.
:Changes in blood morphology and chosen biochemical parameters in ultra-marathon runners during a 100-km run in relation to the age and speed of runners. Int J Occup Med Environ Health 2016; 29: 801–814.
, :Influence of a 100-km ultra-marathon on hepatitis B carrier runners. Int J Sports Med 2013; 34: 841–845.
, :Serum enzyme levels and lipid peroxidation in ultramarathon runners. Ann Sports Med 1986; 3: 39–41.
:The responses of plasma biochemical parameters to a 56-km race in novice and experienced ultra-marathon runners. Eur J Appl Physiol Occup Physiol 1982; 49: 179–186.
:Effects of an extreme endurance ultra-marathon on musculoskeletal and hematologic functions. Gazz Med Ital 2014; 173: 283–289.
, :Damage to liver and skeletal muscles in marathon runners during a 100 km run with regard to age and running speed. J Hum Kinet 2015; 45: 93–102.
:Sarcomere disruptions of slow fiber resulting from mountain ultramarathon. Int J Sports Physiol Perform 2015; 10: 1041–1047.
, :Effect of a prolonged endurance marathon on vascular endothelial and inflammation markers in runners with exercise-induced hypertension. Am J Phys Med Rehabil 2013; 92: 513–522.
:Exercise and serum enzymes. Japan J Phys Fitness Sports Med 2002; 51: 407–422.
:Muscle pain and biochemical changes after an ultramarathon in cold weather condition – Influence of diclofenac treatment. Schweiz Z Med Traumatol 1994; 2: 30–36.
, :Elevated serum creatine kinase MB and creatine kinase BB-isoenzyme fractions after ultra-marathon running. Eur J Appl Physiol Occup Physiol 1983; 52: 75–79.
, :Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley. Clin Res Cardiol 2007; 96: 359–364.
, :Increasing creatine kinase concentrations at the 161-km western states endurance run. Wilderness Environ Med 2012; 23: 56–60.
:A randomized controlled trial of massage and pneumatic compression for ultramarathon recovery. J Orthop Sports Phys Ther 2016; 46: 320–326.
:Changes in the markers of cardiac damage in men following long-distance and ultra-long-distance running races. J Sports Med Phys Fitness 2016; 56: 295–301.
, :Physiological responses to prolonged exercise in ultramarathon athletes. J Appl Physiol 1986; 61: 611–617.
:Time course of recovery of vertical jump height and heart rate versus running speed after a 90-km foot race. J Sports Sci 1998; 16: 645–651.
, :A faster running speed is associated with a greater body weight loss in 100-km ultra-marathoners. J Sports Sci 2012; 30: 1131–1140.
, :Branched-chain amino acid supplementation during a 100-km ultra-marathon – A randomized controlled trial. J Nutr Sci Vitaminol (Tokyo) 2012; 58: 36–44.
, :No effect of short-term amino acid supplementation on variables related to skeletal muscle damage in 100 km ultra-runners – a randomized controlled trial. J Int Soc Sports Nutr 2011; 8: 6.
, :Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun 2006; 20: 578–584.
, :Antioxidants did not prevent muscle damage in response to an ultramarathon run. Med Sci Sports Exerc2006; 38: 72–80.
, :Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004; 36: 1329–1341.
:Hemolysis and rhabdomyolysis after marathon and long distance running. Immunol Endocr Metab Agents Med Chem 2012; 12: 8–13.
:Extreme endurance training evidence of capillary and mitochondria compartmentalization in human skeletal muscle. Eur J Appl Physiol 1991; 63: 173–178.
, :A 246-km continuous running race causes significant changes in bone metabolism. Bone 2009; 45: 1079–1083.
, :Bone turnover response is linked to both acute and established metabolic changes in ultra-marathon runners. Endocrine 2017; 56: 196–204.
, :Schadet Marathonlaufen dem Stütz- und Bewegungsapparat? Dtsch Z Sportmed 2011: 62, 299–303.
: